** Shares of medical device maker Baxter BAX.N rise 1.5% to $31.65
** BAX reports Q1 adj. profit of 55 cents per share, surpassing analysts' average estimate of 48 cents, according to data compiled by LSEG
** Co posts Q1 revenue of $2.63 billion, exceeding estimate of $2.59 billion
** BAX raises the lower end of its 2025 profit forecast range to $2.47 to $2.55 per share, compared with a prior view of $2.45 to $2.55
** Including session's moves, BAX stock up 9.02% YTD
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。